Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention

By Wang Lin   Sassi Alexandra Beumer   Patton Dorothy   Isaacs Charles   Moncla B. J.   Gupta Phalguni   Rohan Lisa Cencia  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 8, 2012-08 ,pp. : 995-1007

Informa Healthcare

Access to resources Recommend Favorite

Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-04 ,pp. : 1118-1134

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV microbicide development: targeting the virus is the key

By O’’Keefe Barry R  

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 553-556

Future Medicine

Access to resources Recommend Favorite

Antiretroviral prophylaxis prevents vaginal HIV-1 transmission in mice

By  

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea])

By D'Cruz Osmond J   Qazi Sanjive   Yiv Seang   Uckun Fatih M  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 265-279

Informa Healthcare

Access to resources Recommend Favorite